Carrington Announces Results Of Aliminase Clinical

Carrington Laboratories, Inc. announced the results of its Phase III pivotal trial with Aliminase for ulcerative colitis.

Indications were that no significant differences were found to support a therapeutic drug effect.

In light of these results, the company plans to discontinue the development and testing of Aliminase as a treatment for ulcerative colitis.

“Although we are disappointed with the results of the ulcerative colitis study, this is only one of several research efforts underway designed to exploit the biological activity of the complex carbohydrates refined from the Aloe vera plant. We should not lose sight of the fact that has profitable operations in wound care, AloeCeuticals and raw materials manufacturing, which have provided the cashflow for its research and development efforts and for the clinical trials without incurring any long-term debt.

Indeed, in 1999, operations without the clinical research expense of the ulcerative colitis study would have produced a profit of $1.875 million and an EBITDA of $2.78 million,” said Dr. Carlton Turner, president and CEO.

“Carrington will continue discovery and pre-clinical research to identify new drug leads, however, the company’s future strategy will be to seek pharmaceutical partners for the clinical development of these leads.

At the present time, Carrington is investigating an injectable product for the treatment of neutropenia and the use of its proprietary pectin as a drug delivery vehicle,” continued Turner.

“As we move forward, Carrington will be able to redeploy cashflow used by the clinical trials to concentrate its efforts in health services, AloeCeuticals and continued expansion of its Manapol franchise.

Business development issues will focus on aggressive national and international growth of the health services division, which includes wound care and oral technology products.

The regional and national roll out of the new AloeCeuticals brand of products containing Manapol will be accelerated,” Turner further stated.

Carrington Laboratories, Inc., is an ISO 9001-certified, research-based biopharmaceutical company currently utilizing naturally-occurring complex carbohydrates to manufacture and market products for mucositis, radiation dermatitis, wound and oral care; manufacture and market the nutraceutical raw material Manapol; and market consumer products under the AloeCeuticals brand.

Carrington‘s technology is protected by more than 119 patents in 26 countries.

Obtain Dragon Pharma LLC Legally

Tritren 150

Injectable Anabolic Steroid
Prime Substance: Trenbolones Blend
Branded by: Dragon Pharmaceuticals
Amount: 1 X 10 ml (150 mg/ml)

Clenbuterol - Cheap Price

Administration: Oral
Basal Substance: Clenbuterol Hydrochloride
Producer: Dragon Pharma
Package: 20 x 100 tablets (40 mcg/tab)
Price: 20 x $25

Cypionat 250 - Cheap Price

Administration: Injection
Active Chemical Name: Testosterone Cypionate
Made by: Dragon Pharmaceutical
Package: 20 x 10 mL vial (250 mg/mL)
Price: 20 x $30.00

Masteron 200 - Bulk Price

Administration: Injection
Active Chemical Name: Drostanolone Enanthate
Made by: Dragon Pharma
Pack: 10 x 10 mL vial (200 mg/mL)
Price: 10 x $67.00

Winstrol Tabs - Cheap Price

Administration: Oral
Prime Substance: Stanozolol
Producer: Dragon Pharma Labs
Package: 20 x 100 tablets (50 mg/tab)
Price: 20 x $58.00

Dianabol 20 - Bulk Price

Administration: Oral
Basic Substance: Methandrostenolone
Produced by: Dragon Pharma Labs
Unit: 10 x 100 pills (20 mg/tablet)
Price: 10 x $39.00

Masteron 100

Injectable Steroid for Muscle Growth
Basic Substance: Drostanolone Di-Propionate
Produced by: Dragon Pharma Labs
10 mL Sterile Multi-dose Vial (100 mg/mL)

Primobolan 100

Injectable Steroid for Muscle Growth
Primary Substance: Methenolone Enanthate
Produced by: Dragon Pharma Labs
10 mL Sterile Multi-dose Vial (100 mg/mL)

Deca 500

Injectable Steroid for Muscle Growth
Basal Substance: Nandrolone Decanoate
Produced by: Dragon Pharmaceuticals
10 mL Sterile Multi-dose Vial (500 mg/mL)

EQ 300

Base Constituent: Boldenone Undecylenate
Branded by: Dragon Pharmaceuticals
Amount: 10 x 10 mL vial (300 mg/mL)

Enantat 250

Primary Constituent: Testosterone Enanthate
Produced by: Dragon Pharmaceutical
Pack: 10 x 10 mL vial (250 mg/mL)

Parabolan 100

Primary Component: Trenbolone Hexahydrobenzylcarbonate
Producer: Dragon Pharmaceuticals
Amount: 10 mL vial (100 mg/mL)